Extendicare (TSE:EXE) Stock Passes Above 200-Day Moving Average – Here’s What Happened

Extendicare Inc. (TSE:EXEGet Free Report)’s stock price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of C$10.53 and traded as high as C$13.31. Extendicare shares last traded at C$13.30, with a volume of 261,885 shares changing hands.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Cormark upgraded shares of Extendicare to a “moderate buy” rating in a research note on Wednesday, February 19th. TD Securities raised their price objective on shares of Extendicare from C$10.50 to C$13.00 and gave the company a “hold” rating in a research report on Monday, March 3rd. Finally, BMO Capital Markets lifted their price objective on Extendicare from C$11.00 to C$13.50 in a report on Monday, March 3rd.

Check Out Our Latest Report on EXE

Extendicare Stock Performance

The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The stock’s 50 day moving average price is C$11.92 and its two-hundred day moving average price is C$10.53. The firm has a market capitalization of C$1.11 billion, a price-to-earnings ratio of 16.96 and a beta of 1.26.

Extendicare Announces Dividend

The business also recently declared a monthly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 17th were given a dividend of $0.04 per share. The ex-dividend date was Friday, February 28th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.61%. Extendicare’s payout ratio is 61.20%.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

See Also

Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.